| 000 | 01212 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515110514.0 | ||
| 264 | 0 | _c20080304 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1558-7673 | ||
| 024 | 7 |
_a10.3816/CGC.2007.n.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmato, Robert J | |
| 245 | 0 | 0 |
_aInhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy. _h[electronic resource] |
| 260 |
_bClinical genitourinary cancer _cDec 2007 |
||
| 300 |
_a422-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aDNA (Cytosine-5-)-Methyltransferase 1 |
| 650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xtherapeutic use |
| 650 | 0 | 4 |
_aThionucleotides _xtherapeutic use |
| 773 | 0 |
_tClinical genitourinary cancer _gvol. 5 _gno. 7 _gp. 422-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CGC.2007.n.029 _zAvailable from publisher's website |
| 999 |
_c17776927 _d17776927 |
||